Stockreport

BioAtla Announces Share Consolidation

BioAtla, Inc.  (BCAB) 
PDF SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development o [Read more]